Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fifth of China Goods Substandard (China)

This article was originally published in PharmAsia News

Executive Summary

The Chinese government reports that almost 20 percent of goods Chinese quality inspectors checked in the first half of this year were below standard. The General Administration of Quality Supervision, Inspection and Quarantine found that 80.9 percent of 7,200 products inspected passed scrutiny and that overall quality was improving. However, 19.1 percent of the tested goods were found to be laced with toxins or too many additives, without safety protections or lacking required label information. The checks did not cover exports, according to the report. Chinese leaders have demanded stricter food and medicine standards after a series of trade disputes over the quality of exports. "When serious quality problems are found, they will be strictly punished according to the law so that product quality is protected from the source," the Administration report said. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066414

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel